YM155 inhibits retinal pigment epithelium cell survival through EGFR/MAPK signaling pathway
AIM: To investigate YM155's effect on retinal pigment epithelium (RPE) cells' viability and the potential regulatory mechanisms. METHODS: Human immortalized RPE cell lines (ARPE-19 cell line) were processed with YM155 and epidermal growth factor (EGF). ARPE-19 cell viability was detected b...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2021-04-01
|
| Series: | International Journal of Ophthalmology |
| Subjects: | |
| Online Access: | http://ies.ijo.cn/en_publish/2021/4/20210402.pdf |
| _version_ | 1818650880764805120 |
|---|---|
| author | Teng Li Hong-Bing Zhang Jia-Min Meng Bo Yuan Wen-Juan Lin Yue Feng Xiao-Dong Chen |
| author_facet | Teng Li Hong-Bing Zhang Jia-Min Meng Bo Yuan Wen-Juan Lin Yue Feng Xiao-Dong Chen |
| author_sort | Teng Li |
| collection | DOAJ |
| description | AIM: To investigate YM155's effect on retinal pigment epithelium (RPE) cells' viability and the potential regulatory mechanisms. METHODS: Human immortalized RPE cell lines (ARPE-19 cell line) were processed with YM155 and epidermal growth factor (EGF). ARPE-19 cell viability was detected by methyl thiazolyl tetrazolium assay, and apoptosis was tested by flow cytometry assay. ARPE-19 cell proliferation was assessed with bromodeoxyuridine tagged incorporation assay, and migration ability was evaluated via a wound-healing assay. Epidermal growth factor receptor (EGFR)/MAPK pathway proteins were tested via immunoblotting. EGFR localization was examined by immunofluorescence assay. RESULTS: YM155 suppressed ARPE-19 cells' viability in a time and concentration-dependent manner. A high dose of YM155 caused a small amount of ARPE-19 cell death. YM155 significantly diminished the ARPE-19 cells' proliferative and migrative capacity. YM155 down-regulated total EGFR and phosphorylated external signal-regulated protein kinase (ERK), and it up-regulated the phosphorylation of P38MAPK and c-Jun N-terminal kinase (JNK). YM155 induced endocytosis of EGFR in ARPE-19 cell. YM155 also attenuated EGF-induced ARPE-19 cells' proliferative and migrative capacity. Moreover, YM155 significantly decreased the expression of phosphorylated EGFR and ERK after treated by EGF. CONCLUSION: YM155 inhibits RPE cell survival, the cell proliferative and migrative capacity, and it effectuates a small amount of cell death through the EGFR/MAPK signaling pathway. YM155 might, therefore, be an agent to prevent and treat abnormal RPE cell survival in proliferative vitreoretinopathy. |
| first_indexed | 2024-12-17T01:57:15Z |
| format | Article |
| id | doaj.art-1496914b67484bad93a4e407792ca596 |
| institution | Directory Open Access Journal |
| issn | 2222-3959 2227-4898 |
| language | English |
| last_indexed | 2024-12-17T01:57:15Z |
| publishDate | 2021-04-01 |
| publisher | Press of International Journal of Ophthalmology (IJO PRESS) |
| record_format | Article |
| series | International Journal of Ophthalmology |
| spelling | doaj.art-1496914b67484bad93a4e407792ca5962022-12-21T22:07:56ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982021-04-0114448949610.18240/ijo.2021.04.0220210402YM155 inhibits retinal pigment epithelium cell survival through EGFR/MAPK signaling pathwayTeng Li0Hong-Bing Zhang1Jia-Min Meng2Bo Yuan3Wen-Juan Lin4Yue Feng5Xiao-Dong Chen6Xiao-Dong Chen. Department of Ophthalmology, Xi'an No.1 Hospital, Xi'an 710002, Shaanxi Province, China. cxd390203850@163.comFirst Affiliated Hospital of Northwest University, Northwest University, Xi'an 710069, Shaanxi Province, China; College of Life Sciences, Northwest University, Xi'an 710069, Shaanxi Province, China; Department of Ophthalmology, Xi'an No.1 Hospital, Xi'an 710002, Shaanxi Province, China; Shaanxi Institute of Ophthalmology, Shaanxi Provincial Key Lab of Ophthalmology, Clinical Research Center for Ophthalmology Diseases of Shaanxi Province, Xi'an 710002, Shaanxi Province, ChinaFirst Affiliated Hospital of Northwest University, Northwest University, Xi'an 710069, Shaanxi Province, China; College of Life Sciences, Northwest University, Xi'an 710069, Shaanxi Province, ChinaFirst Affiliated Hospital of Northwest University, Northwest University, Xi'an 710069, Shaanxi Province, China; College of Life Sciences, Northwest University, Xi'an 710069, Shaanxi Province, ChinaFirst Affiliated Hospital of Northwest University, Northwest University, Xi'an 710069, Shaanxi Province, China; College of Life Sciences, Northwest University, Xi'an 710069, Shaanxi Province, ChinaFirst Affiliated Hospital of Northwest University, Northwest University, Xi'an 710069, Shaanxi Province, China; College of Life Sciences, Northwest University, Xi'an 710069, Shaanxi Province, ChinaFirst Affiliated Hospital of Northwest University, Northwest University, Xi'an 710069, Shaanxi Province, China; College of Life Sciences, Northwest University, Xi'an 710069, Shaanxi Province, China; Department of Ophthalmology, Xi'an No.1 Hospital, Xi'an 710002, Shaanxi Province, China; Shaanxi Institute of Ophthalmology, Shaanxi Provincial Key Lab of Ophthalmology, Clinical Research Center for Ophthalmology Diseases of Shaanxi Province, Xi'an 710002, Shaanxi Province, ChinaAIM: To investigate YM155's effect on retinal pigment epithelium (RPE) cells' viability and the potential regulatory mechanisms. METHODS: Human immortalized RPE cell lines (ARPE-19 cell line) were processed with YM155 and epidermal growth factor (EGF). ARPE-19 cell viability was detected by methyl thiazolyl tetrazolium assay, and apoptosis was tested by flow cytometry assay. ARPE-19 cell proliferation was assessed with bromodeoxyuridine tagged incorporation assay, and migration ability was evaluated via a wound-healing assay. Epidermal growth factor receptor (EGFR)/MAPK pathway proteins were tested via immunoblotting. EGFR localization was examined by immunofluorescence assay. RESULTS: YM155 suppressed ARPE-19 cells' viability in a time and concentration-dependent manner. A high dose of YM155 caused a small amount of ARPE-19 cell death. YM155 significantly diminished the ARPE-19 cells' proliferative and migrative capacity. YM155 down-regulated total EGFR and phosphorylated external signal-regulated protein kinase (ERK), and it up-regulated the phosphorylation of P38MAPK and c-Jun N-terminal kinase (JNK). YM155 induced endocytosis of EGFR in ARPE-19 cell. YM155 also attenuated EGF-induced ARPE-19 cells' proliferative and migrative capacity. Moreover, YM155 significantly decreased the expression of phosphorylated EGFR and ERK after treated by EGF. CONCLUSION: YM155 inhibits RPE cell survival, the cell proliferative and migrative capacity, and it effectuates a small amount of cell death through the EGFR/MAPK signaling pathway. YM155 might, therefore, be an agent to prevent and treat abnormal RPE cell survival in proliferative vitreoretinopathy.http://ies.ijo.cn/en_publish/2021/4/20210402.pdfym155retinal pigment epithelial cellepidermal growth factor receptormitogen-activated protein kinase |
| spellingShingle | Teng Li Hong-Bing Zhang Jia-Min Meng Bo Yuan Wen-Juan Lin Yue Feng Xiao-Dong Chen YM155 inhibits retinal pigment epithelium cell survival through EGFR/MAPK signaling pathway International Journal of Ophthalmology ym155 retinal pigment epithelial cell epidermal growth factor receptor mitogen-activated protein kinase |
| title | YM155 inhibits retinal pigment epithelium cell survival through EGFR/MAPK signaling pathway |
| title_full | YM155 inhibits retinal pigment epithelium cell survival through EGFR/MAPK signaling pathway |
| title_fullStr | YM155 inhibits retinal pigment epithelium cell survival through EGFR/MAPK signaling pathway |
| title_full_unstemmed | YM155 inhibits retinal pigment epithelium cell survival through EGFR/MAPK signaling pathway |
| title_short | YM155 inhibits retinal pigment epithelium cell survival through EGFR/MAPK signaling pathway |
| title_sort | ym155 inhibits retinal pigment epithelium cell survival through egfr mapk signaling pathway |
| topic | ym155 retinal pigment epithelial cell epidermal growth factor receptor mitogen-activated protein kinase |
| url | http://ies.ijo.cn/en_publish/2021/4/20210402.pdf |
| work_keys_str_mv | AT tengli ym155inhibitsretinalpigmentepitheliumcellsurvivalthroughegfrmapksignalingpathway AT hongbingzhang ym155inhibitsretinalpigmentepitheliumcellsurvivalthroughegfrmapksignalingpathway AT jiaminmeng ym155inhibitsretinalpigmentepitheliumcellsurvivalthroughegfrmapksignalingpathway AT boyuan ym155inhibitsretinalpigmentepitheliumcellsurvivalthroughegfrmapksignalingpathway AT wenjuanlin ym155inhibitsretinalpigmentepitheliumcellsurvivalthroughegfrmapksignalingpathway AT yuefeng ym155inhibitsretinalpigmentepitheliumcellsurvivalthroughegfrmapksignalingpathway AT xiaodongchen ym155inhibitsretinalpigmentepitheliumcellsurvivalthroughegfrmapksignalingpathway |